Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

49 results about "HATU" patented technology

HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, Hexafluorophosphate Azabenzotriazole Tetramethyl Uronium) is a reagent used in peptide coupling chemistry to generate an active ester from a carboxylic acid. HATU is used along with Hünig's base (N,N-diisopropylethylamine, DIPEA), or triethylamine to form amide bonds. Typically DMF is used as solvent, although other polar aprotic solvents can also be used.

Omariglonide intermediate as well as synthesis method and application thereof

The invention discloses an omariglitazone intermediate as well as a synthesis method and application thereof, and belongs to the technical field of pharmaceutical chemistry synthesis. The invention provides a synthesis method of an omarigliflozin intermediate and application of the intermediate in synthesis of omarigliflozin. The key of the synthesis method provided by the invention lies in the deprotection process of polycyclic indole amide, nitrile groups are not hydrolyzed, indole carboxylic acid is generated with high selectivity, molecular lactamization is avoided in the condensation process with polycyclic imine B, and expensive amidation reagents such as HATU are not needed in the process, so that the synthesis method is simple and easy to implement. And the purpose of preparing omariglitazone with low cost and high yield is achieved. The synthesis method has the advantages of easily available raw materials, mild reaction conditions, small side reaction influence, simplicity and convenience in operation and high yield, improves the yield, is easy to purify, and is suitable for industrial production of omariglitazone.
Owner:HENAN ACADEMY OF SCI CHEM RES INST CO LTD +1

Preparation method of urea type HATU

The invention provides a preparation method of urea type HATU, which comprises the following steps: step S1, carrying out reaction on N-hydroxy-7-aza-benzotriazole and inorganic alkali to obtain N-hydroxy-7-aza-benzotriazole salt; and step S2, enabling the N-hydroxy-7-aza-benzotriazole salt to react with tetramethyl chlorourea hexafluorophosphate, so as to generate the urea type HATU. The preparation method disclosed by the embodiment of the invention is simple in process, easy to operate, low in synthesis cost, high in experimental safety, easy in condition control and suitable for industrial production.
Owner:ANHUI HIGHFINE BIOTECH CO LTD

Lefanacin and preparation method thereof

The preparation method comprises the following steps: dissolving a compound 1 and a compound 2 in a certain volume of acetonitrile, adding HATU, and generating a crude product solution of the lefanacin at a certain temperature; and purifying the crude product solution of the lehanakine to obtain the high-purity lehanakine. The ratio of the volume of acetonitrile to the mass of the compound 1 is preferably (15-30) ml: 1g, the reaction temperature is preferably 25-35 DEG C, and the reaction time is longer than or equal to 2 hours. According to the present invention, the reaction solvent, the reaction temperature and the reaction time are optimized, and the amide condensation catalyst with the high activity is selected, such that the reaction efficiency of the compound 1 and the compound 2 is high, the lefanacin yield is significantly improved, and the high-purity lefanacin is obtained after purification.
Owner:BEIJING SUN-NOVO PHARM RES CO LTD

Quinolinone derivative and preparation method thereof

The invention discloses a quinolinone derivative and a preparation method thereof, and the quinolinone derivative comprises a 3-phenyl-6, 7-dimethoxy isoquinolin-1 (2H)-one derivative and a 3-phenyl-6, 7-dimethoxy quinolin-2 (1H)-one derivative which are shown in the structural general formulas of formula (I) and formula (II). Wherein 4, 5-dimethoxy-2-methyl benzaldehyde is synthesized firstly, then the 4, 5-dimethoxy-2-methyl benzaldehyde and substituted cyanophenyl are subjected to cycloaddition reaction under the action of potassium tert-butoxide and LiHMDS, and the 4, 5-dimethoxy-2-methyl benzaldehyde is obtained; the preparation method of the 2-(substituted phenyl)-N-(2-formyl-4, 5-dimethoxyphenyl) acetamide comprises the following steps: synthesizing 2-amino-4, 5-dimethoxybenzaldehyde, carrying out acylation reaction on the 2-amino-4, 5-dimethoxybenzaldehyde and substituted phenylacetic acid under the action of HATU to obtain 2-(substituted phenyl)-N-(2-formyl-4, 5-dimethoxyphenyl) acetamide, and carrying out cyclization reaction on the 2-(substituted phenyl)-N-(2-formyl-4, 5-dimethoxyphenyl) acetamide under the action of K2CO3 to obtain the 2-(substituted phenyl)-N-(2-formyl-4, 5-dimethoxyphenyl) acetamide. The preparation method has the characteristics of mild reaction conditions, simplicity in operation, high efficiency, environment friendliness and the like.
Owner:HUNAN UNIV +1

Environment-friendly and efficient Difelikefalin preparation method

The invention relates to the technical field of biological medicine manufacturing, in particular to an environment-friendly and efficient Difelikefalin preparation method. According to the method, a solid-phase peptide synthesis technology is adopted, and the core is that a green mixed solvent system composed of 2-methyltetrahydrofuran and cyclopentyl methyl ether is used for comprehensively replacing traditional toxic solvents such as DMF and DCM. The method comprises the steps of resin swelling, Fmoc deprotection, amino acid coupling, peptide chain cutting, purification and freeze drying, a piperidine / 2-MeTHF solution is adopted in the deprotection, an optimized HATU / DIPEA activation system is adopted in the coupling reaction, a TFA / 2-MeTHF / water mixed solution is adopted in the cutting, and an ethanol-water chromatographic system is adopted in the purification. According to the invention, closed-loop circulation of the solvent is also realized, and 2-MeTHF and CPME are purified through rotary evaporation and reused in the synthesis process. According to the method, high purity and high yield of the product are guaranteed, production toxicity and environmental hazards are remarkably reduced, and the method has excellent industrial application prospects.
Owner:SHENZHEN BAICHUAN HONGPEI BIOTECHNOLOGY CO LTD

Preparation method of Tovorafenib

The invention relates to a preparation method of Tovorafenib (Tovorafenib). According to the preparation method disclosed by the invention, HATU is adopted for amidation, so that the reaction time can be effectively shortened, and the yield can be improved; according to the invention, an amino-free compound is selected as an initial raw material, so that the interference of amino on the reaction during amidation is avoided, and the reaction yield is increased; according to the preparation method disclosed by the invention, a cyclic compound is constructed from an initial raw material and then is combined into a target product, the existing commercial compound is selected, key synthesis steps are focused, the operation method is simple and convenient, and the reaction steps are greatly shortened; the post-treatment of the multi-step reaction is simple, and the method is suitable for batch production.
Owner:WUHAN JIUZHOU YUMIN PHARM TECH CO LTD

Novel probe for monitoring activity of glutamyltranspeptidase as well as preparation method and application of novel probe

The invention provides a novel probe for monitoring activity of glutamyltranspeptidase as well as a preparation method and application of the novel probe. The preparation method comprises the following steps: (S10) preparing a hemicyanine photoacoustic group containing two hydrophilic sulfonic groups and a hemicyanine molecular solution; (S20) dissolving N-Boc-Glu-OtBu and HATU in an organic solvent, adding DMAP, activating at 0-4 DEG C, adding the hemicyanine molecular solution prepared in the step (S10), and continuously stirring to react; (S30) removing unreacted raw materials and byproducts through washing and drying operations; and (S40) obtaining a target product GGT-probe through an acidic deprotection step and a silica gel column chromatography method, the target product GGT-probe has strong hydrophilicity, can monitor the activity of GGT in a living body level in a non-invasive manner by utilizing the photoacoustic property derived from hemicyanine, and is suitable for being applied to monitoring liver functions and systemic lipid metabolism diseases.
Owner:NINGBO FIRST HOSPITAL

Reagent JP236 for extracting germanium from copper smoke dust leachate as well as preparation method and application of reagent JP236

The invention discloses a reagent JP236 for extracting germanium from copper smoke dust leachate as well as a preparation method and application of the reagent JP236, and the reagent JP236 for extracting germanium from the copper smoke dust leachate is prepared by taking polyethylene glycol 2000, triethanolamine and 2-(7-azabenzotriazole)-N, N, N ', N'-tetramethylurea hexafluorophosphate (HATU) as raw materials. The preparation method comprises the following steps: carrying out pressurized reaction on polyethylene glycol 2000, triethanolamine and 2-(7-azabenzotriazole)-N, N, N ', N'-tetramethylurea hexafluorophosphate (HATU) according to a formula ratio in an oxygen atmosphere, thereby obtaining the product.
Owner:KUNMING METALLURGY INST

Pharmaceutical synthesis process of Tovorafenib

The invention relates to a pharmaceutical synthesis process of Tovorafenib (Tovorafenib). According to the synthesis process and the related preparation method of the chiral alpha-miscellaneous amine, prochiral ketone is directly reduced and aminated into optical pure chiral alpha-miscellaneous amine by a one-step method under a mild condition by utilizing a biocatalyst amine dehydrogenase, the defects of the existing catalysis technology can be overcome, the process route is simple, the reaction condition is mild, the yield is high, and the method is suitable for industrial production. The method has green synthesis advantages of step economy, atom economy and the like, and has the advantages of good stereoselectivity (ee value is as high as 99%) and the like. In the synthesis route, a method of condensing amino and carboxyl in an HATU and alkaline environment is mostly adopted, the operation is simple, the reaction yield is high, and the method is suitable for batch production.
Owner:WUHAN JIUZHOU YUMIN PHARM TECH CO LTD

Synthesis and application of 2-(cyclopropanecarboxamide)thiazole-4-carboxamide derivatives

The application relates to the technical field of drug synthesis, in particular to a synthesis method and application of a 2-(cyclopropylamide)thiazole-4-amide derivative. The thiazole structure is shown in formula I. The preparation method of the 2-(cyclopropylamide)thiazole-4-amide derivative is as follows: the compound shown in formula I is obtained by reacting the compound shown in formula II in the presence of HATU, DIPEA, a primary amine or a secondary amine and tetrahydrofuran. The 2-(cyclopropylamide)thiazole-4-amide derivative has the effect of relieving Alzheimer's disease, and is characterized by strong cholinesterase inhibition activity.
Owner:JIANGSU OCEAN UNIV +2

Fluorescent probe for identifying lithium ions as well as preparation method and application of fluorescent probe

The invention discloses a fluorescent probe for recognizing lithium ions and a preparation method and application thereof.The method comprises the steps that rhodamine B, HATU and methyl 3-amino-3-methyl-1-butyrate are mixed and subjected to a first-step reaction, a first reactant is obtained, the first reactant, ethyl alcohol and sodium hydroxide are mixed and subjected to a second-step reaction, a second reactant is obtained and subjected to a third-step reaction, and the fluorescent probe for recognizing the lithium ions is obtained. And mixing the second reactant, crown ether, EDCI and HOBT, and carrying out a third-step reaction to obtain the fluorescent probe. According to the method, lithium ions in a complex environment can be efficiently recognized, and raw material waste and resource loss in the production process are avoided.
Owner:PETROCHINA CO LTD

Artesunate-ebbeselenium derivative as well as preparation method and application thereof

The invention discloses a series of artesunate-ebbeselenium derivatives which are novel in structure and good in biological activity, and discloses a preparation method and application of the artesunate-ebbeselenium derivatives. The preparation method comprises the following steps: taking compounds as shown in a formula (III) and a formula (IV), respectively mixing the compounds with artesunate, HATU, triethylamine or EDCI and DMAP, respectively putting the mixture into an organic solvent, reacting at room temperature, recovering the solvent from the obtained reaction materials, and respectively obtaining target compound crude products; # imgabs0 #; wherein R represents a hydrogen atom, a halogen atom or a methoxy group, or a C9-C12 alkyl group, a methoxy group or a halogen atom. Test results of the applicant show that part of the target compounds have good anti-tumor activity on various tumor cell strains, and are expected to be used for preparing anti-tumor drugs.
Owner:GUILIN MEDICAL UNIVERSITY

Photosensitizer for inducing tumor cell copper death under illumination as well as preparation method and application of photosensitizer

The invention discloses a photosensitizer for inducing tumor cell copper death under illumination as well as a preparation method and application of the photosensitizer. The structure of the photosensitizer is as shown in a formula I, the core of the photosensitizer is bivalent copper ions, and a ligand is prepared by adopting Nile blue as a parent, adopting HATU / DIPEA catalytic amidation collaborative design with 8-hydroxyquinoline carboxylic acid and adopting a copper salt complexing process; under the triggering of 660nm near-infrared light (20mW / cm < 2 >), the photosensitizer can release GSH complexed copper ions (58%) by generating superoxide anions, specifically down-regulate FDX1 protein (less than 64%) and induce DLAT aggregation, so that the photodynamic-copper death synergistic treatment is realized, the median inhibitory concentration (IC50) on a breast cancer 4T1 model reaches 226nM and is reduced by 50% compared with that of a traditional photosensitizer, the liver accumulation is less than or equal to 0.5 mu M, and the photosensitizer has high efficiency and safety.
Owner:DALIAN UNIV OF TECH

A probe for monitoring the activity of glutamyl transpeptidase, a preparation method thereof, and applications

The present invention provides a novel probe for monitoring the activity of glutamyl transpeptidase, a preparation method and applications, comprising the following steps: (S10) preparing a hemicyanine photoacoustic group containing two hydrophilic sulfonic acid groups and a hemicyanine molecular solution; (S20) dissolving N-Boc-Glu-OtBu and HATU in an organic solvent, adding DMAP, activating at 0-4 °C, and adding the hemicyanine molecular solution prepared in the step (S10) and continuously stirring for reaction; (S30) removing unreacted raw materials and by-products through washing with water and drying operations; (S40) obtaining the target product GGT-probe probe through an acidic deprotection step and silica gel column chromatography. The probe has strong hydrophilicity. By utilizing the photoacoustic properties derived from hemicyanine, it can non-invasively monitor GGT activity at the in vivo level and is suitable for applications in monitoring liver function and systemic lipid metabolism diseases.
Owner:NINGBO FIRST HOSPITAL

Cationic nanocarrier for penetrating fibrocartilage and its preparation method and application

The present invention discloses a cationic nanocarrier for penetrating fibrocartilage and its preparation method and application, which belongs to the field of biomedicine technology. The preparation method comprises the following steps: mixing an ethylenediamine solution and a Boc-Lys(Fmoc)-OH solution, adding HATU and HOAt for activation, adding DIPEA for further activation, stirring the reaction, adding glacial ether and standing to obtain a precursor; mixing the precursor and a piperidine solution, adding glacial ether and n-hexane and standing to obtain DGL; reacting DGL in a mixed solution of TFA, DCM and TIS to obtain de-Boc DGL, and reacting the de-Boc DGL with phenylboronic acid in a solvent. The cationic nanocarrier prepared by the present invention can reversibly bind to glycosaminoglycans in cartilage and penetrate the full layer of condylar cartilage of the temporomandibular joint while carrying siRNA to target deep chondrocytes, giving lysosomal escape ability, promoting chondrocyte uptake, and improving siRNA transfection efficiency.
Owner:SICHUAN UNIV

Anti-myocardial fibrosis compound as well as preparation method and application thereof

The invention discloses an anti-myocardial fibrosis compound as well as a preparation method and application thereof, and belongs to the technical field of medicine synthesis. The preparation method of the compound A comprises the following steps: adding 219 mg of DIPEA into 4 mL of an anhydrous DMF solution containing 100 mg of a compound 6 and 74 mg of a VHL ligand 7, 30 min later, adding 64 mg of HATU, stirring for 4 h at room temperature, pouring the mixture into 40 mL of water, extracting with dichloromethane, combining an organic layer, washing the organic layer with a saturated sodium chloride solution, drying with anhydrous Na2SO4, spin-drying the organic layer at 40 DEG C in vacuum, and separating with a silica gel column. The compound A and the compound B obtained in the invention can significantly reduce the levels of collagen Collagen I and Collagen III of myocardial fibroblasts, and have good anti-myocardial fibrosis effect, and the compound C, the compound D and the compound E have weak anti-myocardial fibrosis effect.
Owner:HEBEI UNIV OF CHINESE MEDICINE

A CPT1A protein degradation targeted chimera and its preparation method and application

The present invention belongs to the field of pharmaceutical technology, and particularly relates to a protein degradation-targeting chimera for CPT1A, its preparation method, and application. (S,R,S)-AHPC-PEG4-NH2 HCl, etomoxir (sodium salt), and DIPEA are added to an organic solvent, followed by HATU, and the reaction is stirred at 20-25°C. After completion of the reaction, the chimera of formula (I) is obtained by purification. A new PROTAC capable of targeted degradation of the CPT1A protein was developed by linking the CPT1A inhibitor etomoxir (sodium salt) to a conjugate of the E3 ubiquitin ligase VHL ligand and a linker. This PROTAC can bind to CPT1A and trigger its effective degradation, significantly downregulating CPT1A levels, and has important application prospects in tumor treatment.
Owner:GENERAL HOSPITAL OF NUCLEAR IND

Proteolytic Targeted Chimera for the Treatment of Multiple Myeloma, its Preparation Method and Application

This invention belongs to the field of heterocyclic compound technology, specifically relating to a protein hydrolysis-targeted chimera for the treatment of multiple myeloma, its preparation method, and its application. Compounds 2, 3, and HATU are dissolved in THF, then DIPEA is added and the reaction is stirred. Water is added to terminate the reaction, followed by extraction, washing, drying, and column chromatography to obtain product 4. Under argon protection, product 4 is dissolved in dichloromethane, then trifluoroacetic acid is added and the reaction is carried out. Toluene is added, and the mixture is distilled under reduced pressure to obtain product 5. Product 5, compound 6, HATU, and DIPEA are dissolved in THF and the reaction is stirred. Water is added to terminate the reaction, followed by extraction, washing, drying, and column chromatography to obtain the protein hydrolysis-targeted chimera for the treatment of multiple myeloma. The protein hydrolysis-targeted chimera for the treatment of multiple myeloma in this invention exhibits significant anti-proliferative activity against RPMI-8266 multiple myeloma cells. The preparation process is simple and suitable for industrial production.
Owner:SHANDONG UNIV OF TECH

Drug-loaded ligand, chromium-based metal-organic framework material and preparation method and application thereof

The application is suitable for the technical field of materials, and provides a drug-loaded ligand, a chromium-based metal organic framework material and a preparation method and application thereof, the preparation method of the drug-loaded ligand comprises the following steps: stirring cysteine methyl ester, HATU, 2,5-di(methoxycarbonyl)benzoic acid and diisopropylethylamine in DMF at room temperature for 12 h, and performing washing and purification treatment; the obtained 2-((3-mercapto-1-methoxy-1-oxoprop-2-yl)carbamoyl) terephthalic acid dimethyl ester is added with 3 mL of a sodium hydroxide aqueous solution in THF / MeOH, stirred at room temperature for 18 h, and subjected to acidification and concentrated acid treatment under reduced pressure to obtain the drug-loaded ligand. The application breaks through the traditional physical adsorption or surface modification by adopting the drug-loaded ligand with a cysteine active group to prepare metal organic framework nanoparticles, and simultaneously realizes drug administration by bonding a functional group with radiation protection capability to the ligand through a ligand doping technology.
Owner:XIAMEN UNIV

Two-channel fluorescent probe for simultaneously detecting A beta and HClO / ClO-, preparation method and application

The invention discloses a dual-channel fluorescent probe for simultaneously detecting A beta and HClO / ClO-as well as a preparation method and application of the dual-channel fluorescent probe, and belongs to the technical field of fluorescent probes. The preparation method comprises the following steps: dissolving 4-(dimethylamino) phenylboronic acid and 4-bromo-2-hydroxybenzaldehyde in ethylene glycol dimethyl ether, adding tetrakis (triphenylphosphine) palladium and a sodium carbonate aqueous solution, reacting to obtain a compound 1, dissolving the compound 1 and monoethyl adipate in dichloromethane, and adding piperidine; reacting to obtain a compound 2; the preparation method comprises the following steps: dissolving methylene blue and sodium carbonate in water and dichloromethane, adding sodium thiosulfate, dropwise adding a dichloromethane solution of triphosgene, reacting to obtain a compound 3, dissolving the compound 3 and triethylamine in dichloromethane, adding 2-(4-aminophenyl) ethylamine, and reacting to obtain a compound 4; and dissolving the compound 2 in dichloromethane, adding DIPEA, HATU and a compound 4, and reacting to obtain the dual-channel fluorescent probe. The dual-channel fluorescent probe shows completely independent spectral response to A beta plaque and HClO / ClO-, and has high selectivity and sensitivity.
Owner:CHINA PHARM UNIV

Preparation method of post-modified MOF (Metal Organic Framework)-based (UiO-66-NH2) pore structure regulation and control material

PendingCN120173256AOrganic acidOrganic solvent
The invention relates to a preparation method of a post-modified MOF (Metal Organic Framework)-based (UiO-66-NH2) pore channel structure regulation and control material. Firstly, UiO-66-NH2 powder is subjected to vacuum drying pretreatment, and meanwhile organic acid, HATU, organic alkali and an anhydrous organic solvent are prepared. The preparation method comprises the following steps: mixing organic acid, HATU and organic alkali according to a specific ratio in an anhydrous environment protected by nitrogen, and stirring at room temperature to activate the organic acid into an active ester intermediate by the HATU; then, pretreated UiO-66-NH2 powder is added, the mixture is heated and stirred for a reaction, the active ester intermediate reacts with amino in UiO-66-NH2, and regulation and control of a pore channel structure are achieved. And after the reaction is finished, carrying out solid-liquid separation through centrifugation or filtration, washing with an anhydrous organic solvent for multiple times, and carrying out vacuum drying to obtain the target material. The method can accurately regulate and control pore channels, conditions are mild and efficient, the performance of the material in the fields of gas adsorption and separation, catalysis, sensing and the like is effectively improved, the application range is expanded, and the remarkable advantages of the material are verified through embodiments and contrast tests.
Owner:CHANGCHUN UNIV OF TECH

Pillyarene WP5-PEG-DNS as well as preparation method and application thereof

The invention discloses pillararene WP5-PEG-DNS and a preparation method and application thereof.The preparation method comprises the steps that under the protection of inert gas, HATU serves as a condensing agent, diisopropylethylamine serves as alkali, DMF serves as a solvent, a compound 1, amino polyethylene glycol, HATU, diisopropylethylamine and DMF are subjected to an amidation reaction, and an intermediate WP5-PEG-NH2 is obtained; the method comprises the following steps: adding an intermediate WP5-PEG-NH2 and 2, 4-dinitrobenzene sulfonyl chloride into a single-neck round-bottom flask, and reacting at room temperature by taking diisopropylethylamine as alkali and CH2Cl2 as a solvent to obtain pillararene WP5-PEG-DNS; the pillararene WP5-PEG-DNS can be used for constructing a nano-drug carrier with excellent water solubility, a chemotherapy drug DOX can be further loaded, combined treatment of chemotherapy and SO2 gas is realized, and the tumor treatment effect is further improved.
Owner:NANTONG UNIV

Preparation method of dabigatran etexilate precursor

PendingCN120923471AOrganic chemistryHATUSide reaction
The invention discloses a preparation method of a dabigatran etexilate precursor, and belongs to the technical field of drug intermediate synthesis. The method comprises the following steps: S1, under the protection of nitrogen, reducing nitro of a compound IV into amino by taking tetrahydroxy diboron and 4, 4 '-dipyridyl as a concerted catalytic system, and purifying to obtain a compound III; s2, pretreating a compound III, a compound II and a condensing agent, performing low-temperature activation and microwave reaction in a DMF / DCM mixed solvent in the presence of HATU, HOAt and DIPEA, and performing post-treatment and recrystallization to obtain an amino amide intermediate; and S3, dissolving the amino amide intermediate in glacial acetic acid, carrying out reflux cyclization, and carrying out post-treatment and recrystallization to obtain a compound I. According to the invention, tetrahydroxy diboron and 4, 4 '-dipyridyl are adopted to synergistically catalyze nitro reduction, the conditions are mild, and the reaction is rapid; by means of synergistic catalysis of HATU and HOAt, water removal through a 4molecular sieve, batch addition of HATU, microwave assistance and the like, the reaction time is shortened, the yield is increased, side reactions are reduced, and the method is suitable for industrial production.
Owner:SUQIAN SHENGJI MEDICAL TECH CO LTD

Eugenol derivative as well as preparation method and application thereof

The invention belongs to the technical field of insecticides, and provides an eugenol derivative as well as a preparation method and application thereof. The method comprises the following steps: mixing a compound 1, a compound 2, a condensing agent and dichloromethane, and reacting to obtain the eugenol derivative, the condensing agent comprises 2-(7-azabenzotriazole)-N, N, N ', N'-tetramethylurea hexafluorophosphate (hereinafter referred to as HATU) and N, N-diisopropylethylamine (hereinafter referred to as DIPEA). The eugenol derivative is designed according to the prodrug principle, hydroxyl easy to oxidize in the eugenol structural formula is protected, the physicochemical property of eugenol is improved, and the solubility and stability of the compound are improved; the eugenol derivative is synthesized through a condensation reaction, the insecticidal activity of the eugenol derivative on tribolium cavaleriei is improved, an important theoretical basis is provided for development of eugenol pilot insecticides, and a reference is provided for prevention and treatment of tribolium cavaleriei pests.
Owner:ANYANG INST OF TECH

A process for the preparation of tovorafenib

The application relates to a preparation method of Tovorafenib. In the preparation method, HATU is used for amidation, reaction time can be effectively reduced, and yield can be improved; in the application, an amine-free compound is selected as an initial raw material, and the interference of an amine group on the reaction is avoided during amidation, so that the reaction yield is improved; in the preparation method, a cyclic compound is constructed from an initial raw material, and then combined into a target product; the existing commercial compound is selected, the key synthesis step is focused on, the operation method is simple, and the reaction steps are greatly shortened; the post-treatment of the multi-step reaction is simple, and the batch production is suitable.
Owner:WUHAN JIUZHOU YUMIN PHARM TECH CO LTD

A process for the synthesis of tovorafenib

The present application relates to a kind of drug synthesis process of Tovorafenib.The synthesis process described in the present application, the preparation method of chiral alpha-heteroamine involved, using biological catalyst amine dehydrogenase, directly under mild conditions, one-step reduction amination of latent chiral ketone is into optical pure chiral alpha-heteroamine, it can overcome the deficiency of existing catalytic technology, process route is simple, reaction condition is mild, yield is high, has the advantages, such as step economy, atom economy and other green synthesis, and the advantages, such as good stereoselectivity (ee value is as high as 99%).The condensation method of amino and carboxyl in the synthesis route described in the present application is mostly under HATU and alkaline environment, simple operation, high reaction yield, suitable for batch production.
Owner:WUHAN JIUZHOU YUMIN PHARM TECH CO LTD

Synthesis and application of 2-(3, 4-dimethoxybenzamido) thiazole-4-amide derivative

The invention relates to the technical field of medicine synthesis, in particular to a synthesis method and application of a 2-(3, 4-dimethoxybenzamido) thiazole-4-amide derivative. The structure of the thiazole is as shown in a formula I in the specification. The preparation method of the 2-(3, 4-dimethoxybenzamido) thiazole-4-amide derivative comprises the following step: reacting a compound shown in a formula I with a compound shown in a formula II in the presence of HATU, DIPEA, primary amine or secondary amine and tetrahydrofuran to obtain the 2-(3, 4-dimethoxybenzamido) thiazole-4-amide derivative. The 2-(3, 4-dimethoxybenzoylamino) thiazole-4-amide derivative disclosed by the invention has a relatively good effect of relieving the Alzheimer's disease, and is characterized by having relatively strong cholinesterase inhibitory activity.
Owner:JIANGSU OCEAN UNIV +2

Proteolysis targeting chimera for treating multiple myeloma as well as preparation method and application of proteolysis targeting chimera

The invention belongs to the technical field of heterocyclic compounds, and particularly relates to a proteolysis targeting chimera for treating multiple myeloma as well as a preparation method and application of the proteolysis targeting chimera. Dissolving the compound 2, the compound 3 and HATU in THF, then adding DIPEA, stirring and reacting, adding water to terminate the reaction, extracting, washing, drying, and carrying out column chromatography to obtain a product 4; under the protection of argon, dissolving the product 4 in dichloromethane, and then adding trifluoroacetic acid for reaction; adding methylbenzene, and performing reduced pressure distillation to obtain a product 5; dissolving the product 5, a compound 6, HATU and DIPEA in THF, and stirring for reaction; and adding water to terminate the reaction, extracting, washing, drying, and carrying out column chromatography to obtain the proteolysis targeting chimera for treating multiple myeloma. The proteolysis targeting chimera for treating multiple myeloma has remarkable anti-proliferative activity on multiple myeloma RPMI-8266 cells, the preparation process is simple, and the chimera is suitable for industrial production.
Owner:SHANDONG UNIV OF TECH

Diagnosis and treatment integrated viscosity response self-assembly nano-micelle as well as preparation method and application thereof

The invention discloses a diagnosis and treatment integrated viscosity response self-assembly nano-micelle as well as a preparation method and application thereof, belongs to the technical field of chemical and biological materials, and aims to solve the problems of curative effect evaluation lagging and invasive detection in existing photo-thermal and photodynamic therapy. The invention provides a preparation scheme of dissolving (E)-3-(5-carboxyl amyl)-2-(2-(5-(4-(diphenylamino) phenyl) thiophene-2-yl) vinyl)-1, 1-dimethyl-1H-benzo [e] indole-3-onium, sulfydryl polyethylene glycol amine, HATU and DIPEA (diisopropylethylamine) in dichloromethane, reacting, self-assembling and purifying, and the obtained nano-micelle has near-infrared fluorescence response and photo-thermal and photodynamic functions. And the curative effect of the drug in treatment of the undifferentiated thyroid cancer can be evaluated in real time by monitoring the viscosity change of a tumor microenvironment.
Owner:SHANXI MEDICAL UNIV

A method for preparing 2-(8-bromoimidazolo[1,5-a]pyridin-3-yl)propane-2-amine

The application discloses a preparation method of 2-(8-bromimidazo[1,5-a]pyridine-3-yl)propane-2-amine and belongs to the technical field of synthesis of pharmaceutical intermediates. The preparation method of 2-(8-bromimidazo[1,5-a]pyridine-3-yl)propane-2-amine comprises the following steps: step one, condensation of compound I and compound II to obtain compound III; step two, dehydration and ring closure of compound III to obtain compound IV; and step three, hydrazinolysis of compound IV to obtain compound V. The compound V is prepared by adopting a new route, the use of HATU and the Burgess reagent is avoided, product purification is simple, the yield is high, the cost is low, and the method is very suitable for industrial production.
Owner:ANQING BAIYI BIOTECHNOLOGY CO LTD